Media Center Found (716)
Array ( [cache_time] => 0 [counts_time] => 0 [query_time] => [total_time] => 0 )
January 13, 2008

The FDA approved the trial at 5 Israeli hospitals and one in Arizona. 

 

More
January 9, 2008

Yissum and Eucalyptus Biosciences Sign Licensing Agreement for the Development of a Small Molecule for the Treatment of Neurodegenerative Diseases

More
December 28, 2007

Israel's Universities and institutes are all about developing and selling technology 

More
December 25, 2007

Yissum and BioLineRx signed a worldwide exclusive license agreement for the development and commercialization of BL-4060, a small molecule drug candidate for the treatment of cancer.

More
December 25, 2007

Yissum announced the formation of Nanolymf, a biotechnology start up company dedicated to advancing a nanotechnology controlled release drug delivery platform that increases the bioavailability of orally administrated lipophilic drugs.

More
December 20, 2007

Jerusalem-based Yissum has formed a spin-off company - Nanolymf, which will

be dedicated to advancing a nanotechnology controlled-release drug delivery platform.

More
December 10, 2007

The Israeli company is developing treatments for various neurological diseases based on a technology licensed from Yissum

More
December 8, 2007

One of Israel's leading biochemists, Prof. Yechezkel Barenholz of the Hebrew University's Hadassah Medical School, has used liposomes to design better drug delivery systems that extend and improve the lives of cancer patients around the...

More
December 2, 2007

US-Israeli biopharmaceutical start-up Medgenics Inc. raised a gross ₤3.3 million in its IPO on London’s Alternative Investment Market (AIM) on Thursday at a company value of ₤10.4 million, after money. The company, which is based on Yissum's...

More
November 26, 2007

People call what Target-In is doing 'guided missiles', and in a way that's exactly what the company's technology is: a guided missile that can recognize and kill inflamed cells from tumors and other diseases. But Target-In's technology is more...

More
November 15, 2007

BioLineRx today announced that it has signed a worldwide exclusive

license agreement with Yissum, the technology transfer company of the Hebrew University of Jerusalem, and Hadasit, the technology transfer company of Hadassah medical...

More
November 7, 2007

Indian API company Century Pharmaceutical has already promised to invest $1 million.

More
November 6, 2007

Yissum Technology Transfer Company of the Hebrew University of Jerusalem has signed a new licensing agreement with a Belgian holding company for the commercialization of a new clean technology developed at the university.

More
November 6, 2007

Yissum Technology Transfer Company of the Hebrew University of Jerusalem has signed a new licensing agreement with a Belgian holding company for the commercialization of a new clean technology developed at the university.

More
November 6, 2007

Yissum Technology Transfer Company of the Hebrew University of Jerusalem has signed a new licensing agreement with a Belgian holding company for the commercialization of a new clean technology developed at the university.

More
November 1, 2007

Various projects in the water, cleantech and alternative energy fields were presented by Yissum at the Watec 2007exhibition, October 30-31, Tel Aviv

More
October 29, 2007

Prof. Nathan Citri of the Hebrew University of Jerusalem invented a kit for the rapid detection of anthrax.

More